Greenply Industries Ltd
₹260.25
+0.95 (0.37%)
Fri, 06 Nov 2026, 00:18 pm
Greenply Industries News
Greenply releases Q2FY27 earnings call audio
Greenply Industries Ltd made the audio recording of its Q2 and H1 FY27 earnings conference call available to investors on October 30, 2026, as per SEBI norms.
30 Oct 2026
companies
Greenply appoints MSKA & Associates as auditors
Greenply Industries board approves MSKA & Associates LLP as statutory auditors for 5 years from 2027, replacing B S R & Co. LLP after their term ends.
29 Oct 2026
companies
Greenply board approves ₹125 crore capacity expansion
Greenply Industries Ltd approved a 15 million sq mtr capacity addition at its Sandila subsidiary. The ₹125 crore investment targets near-term demand exceeding current 98% utilization.
29 Oct 2026
companies
Greenply appoints Gaurav Drolia as CSO
Greenply Industries appointed Gaurav Drolia as EVP and Chief Strategy Officer effective October 31, 2026. He brings over 20 years of experience in deal advisory and restructuring.
29 Oct 2026
companies
Greenply Q2FY27 PAT jumps 167% to ₹42.7 crore
Greenply Industries reported a 16.1% YoY revenue rise to ₹799.7 crore in Q2FY27. Core EBITDA surged 57.2% to ₹89.2 crore, driving PAT up 167.3% to ₹42.7 crore.
29 Oct 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo